Veit Buecklein

GLA/DRST real-world outcome analysis of CAR-T cell therapies for large B-cell lymphoma in Germany

Wolfgang Bethge, Peter Martus, Michael Schmitt et al. · Blood · 2022 · 211 citations · Full text

Medicine, Hematology, Oncology +15

Updated results from phase I dose-escalation study of AMG 330, a bispecific T-cell engager molecule, in patients with relapsed/refractory acute myeloid leukemia (R/R AML).

Farhad Ravandi, Roland B. Walter, Marion Subklewe et al. · Journal of Clinical Oncology · 2020 · 105 citations

Medicine, Oncology, Pharmacology +14

Radiochemotherapy in Combination with Regional Hyperthermia in Preirradiated Patients with Recurrent Rectal Cancer

Valeria Milani, Montserrat Pazos, Rolf D. Issels et al. · Strahlentherapie und Onkologie · 2008 · 42 citations

Medicine, Oncology, Radiation Oncology +15

A comparative view on the expression patterns of PD-L1 and PD-1 in soft tissue sarcomas

Martin F. Orth, Veit Buecklein, Eric Kampmann et al. · Cancer Immunology Immunotherapy · 2020 · 40 citations · Full text

Veterinary Medicine, Oncology, Pathology +15

Safety and tolerability of AMG 330 in adults with relapsed/refractory AML: a phase 1a dose-escalation study

Farhad Ravandi, Marion Subklewe, Roland B. Walter et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2024 · 36 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17